Dear Editor, Anti-gamma-aminobutyric acid-B receptor (GABA B-R) encephalitis, autoimmune encephalitis (AE) associated with anti-neuronal cell surface antibodies, presents with prominent seizures, behavioral changes, and cognitive deficits. Half of the cases of anti-GABA B-R encephalitis have been associated with tumors, especially small-cell lung cancer [1]. Ankylosing spondylitis (AS) is a chronic autoimmune inflammatory condition affecting the spine and sacroiliac joint [2], which leads to back pain and progressive spinal stiffness. However, the co-occurrence of anti-GABA B-R encephalitis and AS has never been reported. Here, we provide a case report of anti-GABA B-R encephalitis coexisting with AS for the first time. A Chinese man, whose HLA-B27 and anti-GABA B-R antibodies were positive, was diagnosed with anti-GABA B-R encephalitis and AS. A 34-year-old man presented with his first generalized tonic-clonic seizure (GTCS) lasting for 1 min, 20 days before this admission. After a neurological evaluation and head computed tomography (CT) scan in the emergency department, he was prescribed sodium valproate 500 mg twice daily. However, he experienced another GTCS which lasted for 3 min, 20 days after his first GTCS. Other symptoms included psychiatric abnormalities, such as irritability, delirium, and behavioral changes, in addition to more frequent seizure attacks observed on the following days. The patient experienced GTCSs one-to-four times daily with each episode lasting for 1-3 min. He reported a history of lower back pain and fatigue for 2 years without any evaluation or treatment. An aunt of the patient had a history of ankylosing spondylitis. Neurological examination showed a decline in cognitive function, which mainly affected short-term memory, and disorientation in time and space was revealed. The results of cranial nerve (the first cranial nerve was not tested), motor system, tendon reflexes, meningeal irritation sign, and Babinski sign examinations were generally normal. It was not possible to completely examine the patient's sensory system or motor coordination. GABA B-R antibodies were found in the serum (1:10) and cerebrospinal fluid (CSF) (1:10) using a Cytometric Bead Array (Fig. 1) (Euroimmun, Lubeck, Germany). Serum and CSF were both negative for antibodies against neuronal surface antigens, including antibodies to N-methyl-D-aspartate (NMDA) receptors, leucine-rich glioma-inactivated protein 1 (LGI1), contactin-associated protein-like 2 (CASPR2), α-amino-3-hydroxy-5-methyl-4isoxazolepropionic acid receptor (AMPAR), dipeptidylpeptidase-like protein-6 (DPPX), and metabotropic glutamate receptor 5 (mGluR5). Tests for paraneoplastic antibodies (anti-Hu, anti-Yo, anti-Ri, anti-GAD, anti-PCA2, anti-Ma2/Ta, anti-CV2/CRMP5, anti-ANNA-3, and antiamphiphysin) in serum and CSF were negative. Antivoltage-gated calcium channel (VGCC) antibodies (using radioimmunoprecipitation) were negative in serum, as Aiqing Li and Weihua Feng contributed equally to this work.